FTC says ViroPharma abused FDA petitioning process
The Federal Trade Commission sued Shire ViroPharma yesterday for allegedly manipulating the Food and Drug Administration citizen petition process to keep its monopoly on a gastrointestinal infection medicine.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10